Renal interstitial fibrosis: A critical evaluation of the origin of myofibroblasts

Contributions to Nephrology

Volumn 169, Issue , 2011, Pages 73-93

  Barnes, Jeffrey L ^a,b   Glass II, William F ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c BOSTWICK LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CHRONIC DISEASE; DISEASE MODEL; EPITHELIUM CELL; FIBROSIS; GUINEA PIG; HUMAN; KIDNEY; KIDNEY DISEASE; MESODERM; MOUSE; MYOFIBROBLAST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RABBIT; RAT;

ANIMALS; CELL DIFFERENTIATION; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FIBROSIS; GUINEA PIGS; HUMANS; KIDNEY; KIDNEY DISEASES; MESODERM; MICE; MYOFIBROBLASTS; RABBITS; RATS;

EID: 79551479332     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000313946     Document Type: Article

References (230)

1. Strutz F, Muller GA: Mechanisms of renal fibrogenesis; in Neilson EG, Couser WG (eds): Immunologic Renal Diseases. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 73- 101.
2. Abrass CK, Adcox MJ, Raugi GJ: Aging- associated chanes in renal extracellular matrix. Am J Pathol 1995;146:742-752.
3. Inserra F, Romano LA, de Cavanagh EM, Ercole L, Ferder LF, Gomez RA: Renal interstitial sclerosis in aging: effects of enalapril and nifedipine. J Am Soc Nephrol 1996;7:676-680.
4. Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ: Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol 1998;9:231-242.
5. Eddy AA: Interstitial nephritis induced by protein- overload proteinuria. Am J Pathol 1989;135:719-733.
6. Nagle RB, Kneiser MR, Bulger RE, Benditt EP: Induction of smooth muscle characteristics in renal interstitial fibroblasts during obstructive nephropathy. Lab Invest 1973;29: 422-427.
7. Chevalier RL, Forbes MS, Thornhill BA: Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009;75:1145-1152.
8. Greenfeld Z, Stillman IE, Brezis M, Rosen S: Medullary injury in the ageing rat kidney: functionalmorphometric correlations. Eur J Clin Invest 1997;27:346-351.
9. Bertani T, Zoja C, Abbate M, Rossini M, Remuzzi G: Age- related nephropathy and proteinuria in rats with intact kidneys expo sed to diets with different protein content. Lab Invest 1989;60:196-204.
10. Brandis A, Bianchi G, Reale E, Helmchen U, Kuhn K: Age- dependent glomerulosclerosis and proteinuria occurring in rats of the Milan normotensive strain and not in rats of the Milan hypertensive strain. Lab Invest 1986;55:234-243.
11. Schulz A, Standke D, Kovacevic L, Mostler M, Kossmehl P, Stoll M, Kreutz R: A major gene locus links early onset albuminuria with renal interstitial fibrosis in the MWF rat with polygenetic albuminuria. J Am Soc Nephrol 2003;14:3081-3089.
12. Sugimoto H, Grahovac G, Zeisberg M, Kalluri R: Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein- 7 and advanced glycation end product inhibitors. Diabetes 2007;56: 1825-1833.
13. Ninichuk V, Kulkarni O, Clauss S, Anders HJ: Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy. Eur J Med Res 2007;12:351-355.
14. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ: Spontaneous murine lupus- like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978;148:1198-1215.
15. Peters H, Border WA, Ruckert M, Kramer S, Neumayer HH, and Noble NA: L- arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis. Kidney Int 2003;63:1382-1392.
16. Cowley BD Jr, Gudapaty S, Kraybill AL, Barash BD, Harding MA, Calvet JP, Gattone VH: Autosomal- dominant polycystic kidney disease in the rat. Kidney Int 1993;43:522-534.
17. Carone FA, Butkowski RJ, Nakamura S, Polenakovic M, and Kanwar YS: Tubular basement membrane changes during induction and regression of drug- induced polycystic kidney disease. Kidney Int 1994;46: 1368-1374.
18. Tapp DC, Wortham WG, Addison JF, Hammonds DN, Barnes JL, Venkatachalam MA: Food restriction retards body growth and prevents end- stage renal pathology in remnant kidneys of rats regardless of protein intake. Lab Invest 1989;60:184-195.
19. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J: Mech anisms involved in the pathogen esis of tubulointerstitial fibrosis in 5/6- nephrectomized rats. Kidney Int 1996;49: 666-678.
20. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Omae T, Fujishima M: Rapidly progressive renal deterioration in partially nephrectomized rats with experimental membranous nephropathy. Nephron 1985;41:359-364.
21. Gong R, Rifai A, Tolbert EM, Biswas P, Centracchio JN, Dworkin LD: Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein- 1 and RANTES. J Am Soc Nephrol 2004;15:2868-2881.
22. Mai M, Geiger H, Hilgers KF, Veelken R, Mann JF, Dammrich J, Luft FC: Early interstitial changes in hypertension- induced renal injury. Hypertension 1993;22:754-765.
23. Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL: Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/ reperfusion injury of a single kidney. Transplantation 1997;64:190-197.
24. Kimura M, Suzuki T, Hishida A: A rat model of progressive chronic renal failure produced by microembolism. Am J Pathol 1999;155:1371-1380.
25. Hewitson TD, Darby IA, Bisucci T, Jones CL, Becker GJ: Evolution of tubulointerstitial fibrosis in experimental renal infection and scarring. J Am Soc Nephrol 1998;9:6326-6342.
26. Eddy AA: Tubulointerstitial nephritis during the heterologous phase of nephrotoxic serum nephritis. Nephron 1991:59:304-313.
27. Eddy AA, Ho GC, Thorner PS: The contribution of antibody- mediated cytotoxicity and immune- complex formation to tubulointerstitial disease in passive Heymann nephritis. Clin Immunol Immunopathol 1992;62:42-55.
28. Eddy AA, Michael AF: Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. Kidney Int 1988;33:14-23.
29. Saito T, Sumithran E, Glasgow EF,Atkins RC: The enhancement of aminonucleoside nephrosis by the coadministration of protamine. Kidney Int 1987;32:691-699.
30. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA: Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int 1991;40:1020-1031.
31. Bertani T, Rocchi G, Sacchi G, Mecca G, Remuzzi G: Adriamycin- induced glomerulosclerosis in the rat. Am J Kidney Dis 1986;7:12-19.
32. Chagnac A, Korzets A, Ben- Bassat M, Zevin D, Hirsh J, Meckler J, Levi J: Uninephrectomy aggravates tubulointerstitial injury in rats with adriamycin nephrosis. Nephron 1994;66:176-180.
33. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G: Tubulo- interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 1986;30:488-496.
34. Okuda S, Tamaki K, Ando T, Nagashima A, Nakayama M, Fukuda K, Higashi H, Fujishima M: Increased expression of Na+/H+ exchanger in the injured renal tissues of focal glomerulosclerosis in rats. Kidney Int 1994;46:1635-1643.
35. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF- beta 1 underlies development of progressive kidney fibrosis. Kidney Int 1994;45:916-927.
36. Narita I, Nakayama H, Goto S, Takeda T, Sakatsume M, Saito A, Nakagawa Y, Arakawa M: Identification of genes specifically expressed in chronic and progressive glomerulosclerosis. Kidney Int 1997;63:S215-S217.
37. Peters H, Border WA, Noble NA: L- Arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis. Kidney Int 1999;55:2264-2273.
38. Kirchhoff F, Krebs C, Abdulhag UN, Meyer- Schwesinger C, Maas R, Helmchen U, Hilgers KF, Wolf G, Stahl RA, Wenzel U: Rapid development of severe end- organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II. Kidney Int 2008;73:643-650.
39. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM: Renal injury from angiotensin II- mediated hypertension. Hypertension 1992;19:464-474.
40. Faulkner JL, Szcykalski LM, Springer F, Barnes JL: Origin of interstitial fibroblasts in an accelerated model of angiotensin II- induced renal fibrosis. Am J Pathol 2005;167:1193-1205.
41. Feld LG, Brentjens JR, Van Liew JB: Renal injury and proteinuria in female spontaneously hypertensive rats. Renal Physiol 1981;4:46-56.
42. Geiger H, Fierlbeck W, Mai M, Ruchti H, Schonfeld V, Dammrich J, Hugo C, Neumayer HH: Effects of early and late antihypertensive treatment on extracellular matrix proteins and mononuclear cells in uninephrectomized SHR. Kidney Int 1997;51:750-761.
43. Jovanovic D, Jovovic D, Mihailovic- Stanojevic N, Miloradovic Z, Dimitrijevic J, Maksic N, Djukanovic L: Influence of carvedilol on chronic renal failure progression in spontaneously hypertensive rats with adriamycin nephropathy. Clin Nephrol 2005;63:446-453.
44. Yu HC, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME, Johnston CI: Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998; 98:2621-2628.
45. Shibota M, Nagaoka A, Shino A, Fujita T: Renin- angiotensin system in stroke- prone spontaneously hypertensive rats. Am J Physiol 1979;236:H409-H416.
46. Rapp JP, Dene H: Development and characteristics of inbred strains of Dahl salt sen sitive and salt- resistant rats. Hypertension 1985;7:340-349.
47. Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG: Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 2003;63:1791-1800.
48. Roson MI, Cavallero S, Della PS, Cao G, Gorzalczany S, Pandolfo M, Kuprewicz A, Canessa O, Toblli JE, Fernandez BE: Acute sodium overload produces renal tubulointerstitial inflammation in normal rats. Kidney Int 2006;70:1439-1446.
49. Kelly FJ, Anderson S, Thompson MM, Oyama TT, Kennefick TM, Corless CL, Roman RJ, Kurtzberg L, Pratt BM, Ledbetter SR: Acute and chronic renal effects of recombinant human TGFbeta2 in the rat. J Am Soc Nephrol 1999;10:1264-1273.
50. Ledbetter S, Kurtzberg L, Doyle S, Pratt BM: Renal fibrosis in mice treated with human recombinant transforming growth factor- beta2. Kidney Int 2000;58:2367-2376.
51. Tang WW, Ulich TR, Lacey DL, Hill DC, Qi M, Kaufman SA, Van GY, Tarpley JE, Yee JS: Platelet- derived growth factor- BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 1996;148:1169-1180.
52. Goyer RA, Miller CR, Zhu SY, and Victery W: Non- metallothioneinbound cadmium in the pathogenesis of cadmium nephrotoxicity in the rat.Toxicol Appl Pharmacol 1989;101: 232-244.
53. Walker RG, Escott M, Birchall I, Dowling JP, Kincaid- Smith P: Chronic progressive renal lesions induced by lithium. Kidney Int 1986;29:875-881.
54. Ueda S, Wakashin M, Wakashin Y, Yoshida H, Lesato K, Mori T, Mori Y, Akikusa B, Okuda K: Experimental gold nephropathy in guinea pigs: detection of autoantibodies to renal tubular antigens. Kidney Int 1986;29: 539-548.
55. Haley DP, Bulger RE, Dobyan DC: The long- term effects of uranyl nitrate on the structure and function of the rat kidney. Virchows Arch B Cell Pathol 1982;41:181-192.
56. Axelsen RA: Nephrotoxicity of mild analgesics in the Gunn strain of rat. Br J Clin Pharmacol 1980;10(Suppl 2):309S- 312S.
57. Bertani T, Perico N, Abbate M, Battaglia C, Remuzzi G: Renal injury induced by long- term administration of cyclosporin A to rats. Am J Pathol 1987;127:569-579.
58. Elzinga LW, Rosen S, Burdmann EA, Hat ton DC, Lindsley J, Bennett WM: The role of renal sympathetic nerves in experimental chronic cyclosporine nephropathy. Transplantation 2000;69:2149-2153.
59. Cosyns JP, Dehoux JP, Guiot Y, Goebbels RM, Robert A, Bernard AM, van Ypersele de SC: Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int 2001;59:2164-2173.
60. Debelle FD, Nortier JL, De Prez EG, Garbar CH, Vienne AR, Salmon IJ, Schodt- Lanckman MM, Vanherweghem JL: Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt- depleted rats. J Am Soc Nephrol 2002;13:431-436.
61. Eddy AA: Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, proteolytic cascades. Kidney Int 1998;53:1182-1189.
62. Axelsen RA: Healed experimental renal papillary necrosis and cortical scarring in the rat from 2- bromoethylamine hydrobromide. Virchows Arch B Pathol Anat Histol 1978;381:63-77.
63. Zahedi K, Revelo MP, Barone S, Wang Z, Tehrani K, Citron DP, Bissler JJ, Rabb H, Soleimani M: Stathmin- deficient mice develop fibrosis and show delayed recovery from ischemic- reperfusion injury. Am J Physiol Renal Physiol 2006;290:F1559-F1567.
64. Powell DW, Bertram CC, Cummins TD, Barati MT, Zheng S, Epstein PN, Klein JB: Renal tubulointerstitial fibrosis in OVE26 type 1 diabetic mice. Nephron Exp Nephrol 2009;111:11-19.
65. Bachmann S, Peters J, Engler E, Ganten D, Mullins J: Transgenic rats carrying the mouse renin gene - morphological characterization of a low- renin hypertension model. Kidney Int 1992;41:24-36.
66. Kelly DJ, Wilkinson- Berka JL, Allen TJ, Cooper ME, Skinner SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen- 2)27 rat (TGR). Kidney Int 1998;54:343-352.
67. Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, Hunter WJ, Samuelson GC: Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome. Genes Dev 1996;10:2981-2992.
68. Miner JH, Sanes JR: Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome. J Cell Biol 1996;135:1403-1413.
69. Matsuo S, Lopez- Guisa JM, Cai X, Okamura DM, Alpers CE, Bumgarner RE, Peters MA, Zhang G, Eddy AA: Multi functionality of PAI- 1 in fibrogenesis: evidence from obstructive nephropathy in PAI- 1- overexpressing mice. Kidney Int 2005;67:2221-2238.
70. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS: Transgenic mice with increased plasma levels of TGF- beta 1 deve lop progressive renal disease. Lab Invest 1996;74:991-1003.
71. Chai Q, Krag S, Chai S, Ledet T, Wogensen L: Localisation and phenotypical characterisation of collagen- producing cells in TGF- beta 1- induced renal interstitial fibrosis. Histochem Cell Biol 2003;119:267-280.
72. Samuel CS, Zhao C, Bond CP, Hewitson TD, Amento EP, Summers RJ: Relaxin- 1- deficient mice develop an age- related progression of renal fibrosis. Kidney Int 2004;65:2054-2064.
73. Yabuki A, Maeda M, Matsumoto M, Kami mura R, Masuyama T, Suzuki S: SAMP1/Sku as a murine model for tubulointerstitial nephritis: a study using unilateral ureteral obstruction. Exp Animals 2005;54:53-60.
74. Takeji M, Moriyama T, Oseto S,Kawada N, Hori M, Imai E, Miwa T: Smooth muscle alpha- actin deficiency in myofibroblasts leads to enhanced renal tissue fibrosis. J Biol Chem 2006;281:40193-40200.
75. Zhang X, Chen X, Hong Q, Lin H, Zhu H, Liu Q, Wang J, Xie Y, Shang X, Shi S, Lu Y, Yin Z: TIMP- 1 promotes agerelated renal fibrosis through upregulating ICAM- 1 in human TIMP- 1 transgenic mice. J Gerontol Series A Biol Sci Med Sci 2006;61:1130-1143.
76. Cai G, Zhang X, Hong Q, Shao F, Shang X, Fu B, Feng Z, Lin H, Wang J, Shi S, Yin Z, and Chen X: Tissue inhibitor of metalloproteinase- 1 exacerbated renal interstitial fibrosis through enhancing inflammation. Nephrol Dial Transplant 2008;23:1861-1875.
77. Kassiri Z, Oudit GY, Kandalam V, Awad A, Wang X, Ziou X, Maeda N,Herzenberg AM, Scholey JW: Loss of TIMP3 enhances interstitial nephritis and fibrosis. J Am Soc Nephrol 2009;20:1223-1235.
78. Kawamoto H, Yasuda O, Suzuki T, Ozaki T, Yotsui T, Higuchi M, Rakugi H, Fukuo K, Ogihara T, Maeda N: Tissue inhibitor of metalloproteinase- 3 plays important roles in the kidney following unilateral ureteral obstruction. Hypertension Res 2006;29:285-294.
79. Boutet A, De Frutos CA, Maxwell PH, Mayol MJ, Romero J, Nieto MA: Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 2006;25:5603-5613.
80. Ramila D, Ardura JA, Esteban V, Ortega A, Ruiz- Ortega M, Bosch RJ, Esbrit P: Parathyroid hormonerelated protein promotes inflammation in the kidney with an obstructed ureter. Kidney Int 2008;73:835-847.
81. Ortega A, Ramila D, Ardura JA, Esteban V, Ruiz- Ortega M, Barat A, Gazapo R, Bosch RJ, Esbrit P: Role of parathyroid hormone- related protein in tubulointerstitial apoptosis and fibrosis after folic acid- induced nephrotoxicity. J Am Soc Nephrol 2006;17:1594-1603.
82. Inagi R, Yamamoto Y, Nangaku M, Usuda N, Okamato H, Kurokawa K, van Ypersele de SC, Yamamoto H, Miyata T: A severe diabetic nephropathy model with early development of nodule- like lesions induced by megsin overexpression in RAGE/ iNOS transgenic mice. Diabetes 2006;55:356-366.
83. Liu E, Morimoto M, Kitajima S, Koike T, Yu Y, Shiiki H, Nagata M, Watanabe T, Fan J: Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions. J Am Soc Nephrol 2007;18:2094-2104.
84. Cheng S, Pollock AS, Mahimkar R, Olson JL, Lovett DH: Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J 2006;20:1898-1900.
85. Kie JH, Kapturczak MH, Traylor A, Agarwal A, Hill- Kapturczak N: Heme oxygenase- 1 deficiency promotes epithelial- mesenchymal transition and renal fibrosis. J Am Soc Nephrol 2008;19:1681-1691.
86. Kosugi T, Heinig M, Nakayama T, Connor T, Yuzawa Y, Li Q, Hauswirth WW, Grant MB, Croker BP, Campbell- Thompson M, Zhang L, Atkinson MA, Segal MS, Nakagawa T: Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice. Am J Pathol 2009;174: 1221-1229.
87. Nakayama T, Sato W, Kosugi T, Zhang L, Campbell- Thompson M, Yoshimura A, Croker BP, Johnson RJ, Nakagawa T: Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse. Am J Physiol Renal Physiol 2009;296:F317-F327.
88. Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, Maeda N, Nishida M, Katsube F, Shimomura I, Ito T, Funahashi T: Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectinknockout mice. Arterioscler Thromb Vasc Biol 2007;27:1910-1917.
89. Bao J, Tu Z, Sun H, Luo G, Yang L, Song J, Qin M, Shi Y, Bu H, Li Y: R2: identification of renal potential progenitor/stem cells that participate in the renal regeneration processes of kidney allograft fibrosis. Nephrology 2008;13:500-507.
90. Gooch JL, Roberts BR, Cobbs SL, Tumlin JA: Loss of the alpha- isoform of calcineurin is sufficient to induce nephrotoxicity and altered expression of transforming growth factor- beta. Transplantation 2007;83: 439-447.
91. Meier M, Menne J, Park JK, Holtz M, Gueler F, Kirsch T, Schiffer M, Mengel M, Lindschau C, Leitges M, Haller H: Deletion of protein kinase C- epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. J Am Soc Nephrol 2007;18:1190-1198.
92. Morimoto Y, Gai Z, Tanishima H, Kawakatsu M, Itoh S, Hatamura I, Muragaki Y: TNF- alpha deficiency accelerates renal tubular interstitial fibrosis in the late stage of ureteral obstruction. Exp Mol Pathol 2008;85:207-213.
93. Kimura K, Iwano M, Higgins DF, Yamaguchi Y, Nakatani K, Harada K, Kubo A, Akai Y, Rankin EB, Neilson EG, Haase VH, Saito Y: Stable expression of HIF- 1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 2008;295: F1023-F1029.
94. Ma J, Nishimura H, Fogo A, Kon V, Inagami T, Ichikawa I: Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 1998;53:937-944.
95. Brantley JG, Sharma M, Alcalay NI, Heuvel GB: Cux- 1 transgenic mice develop glomerulosclerosis and interstitial fibrosis. Kidney Int 2003;63:1240-1248.
96. Norwood VF, Morham SG, Smithies O: Postnatal development and progression of renal dysplasia in cyclooxygenase- 2 null mice. Kidney Int 2000;58:2291-2300.
97. Zhang G, Kim H, Cai X, Lopez- Guisa JM, Alpers CE, Liu Y, Carmeliet P, Eddy AA: Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 2003;14:1254-1271. (Pubitemid 36514666)
98. Schaefer L, Macakova K, Raslik I, Micegova M, Grone HJ, Schonherr E, Robenek H, Echtermeyer FG, Grassel S, Bruckner P, Schaefer RM, Iozzo RV, Kresse H: Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 2002;160:1181-1191.
99. Schanstra JP, Neau E, Drogoz P, revalo Gomez MA, Lopez Novoa JM, Calise D, Pecher C, Bader M, Girolami JP, Bascands JL: In vivo bradykinin B2 receptor activation reduces renal fibrosis. J Clin Invest 2002;110:371-379.
100. Hocher B, Thone- Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Bauer C, Neumayer HH, Schleuning WD, Theuring F: Endothelin- 1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, renal cysts but not hypertension. J Clin Invest 1997;99:1380-1389.
101. Svensson M, Irjala H, Alm P, Holmqvist B, Lundstedt AC, Svanborg C: Natural history of renal scarring in susceptible mIL- 8Rh-/- mice. Kidney Int 2005;67:103-110.
102. Wenderfer SE, Wang H, Ke B, Wetsel RA, Braun MC: C3a receptor deficiency accelerates the onset of renal injury in the MRL/lpr mouse. Mol Immunol 2009;46:1397-1404.
103. Wang Y, Heilig K O, Minto AW, Chen S, Xiang M, Dean DA, Geiger RC, Chang A, Pravtcheva DD, Schlimme M, Deb DK, Wang Y, Heilig CW: Nephron- deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF. Lab Invest 2010;90:83-97.
104. Hewitson TD: Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol 2009;296:F1239-F1244.
105. Schnaper HW: Renal fibrosis. Meth Mol Med 2005;117:45-68.
106. Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199-210.
107. Gabbiani G: The biology of the myofibroblast. Kidney Int 1992;41:530-532.
108. Desmouliere A, Chaponnier C, Gabbiani G: Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005;13:7-12.
109. Desmouliere A, Gabbiani G: Myofibroblast differentiation during fibrosis. Exp Nephrol 1995;3:134-139.
110. Benzonana G, Skalli O, Gabbiani G: Correlation between the distribution of smooth muscle or non muscle myosins and alpha- smooth muscle actin in normal and pathological soft tissues. Cell Motil Cytoskeleton 1988;11:260-274.
111. Gabbiani G: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003;200:500-503.
112. Alpers CE, Pichler R, Johnson RJ: Phenotypic features of cortical interstitial cells potentially important in fibrosis. Kidney Int 1996;54:S28-S31.
113. Alpers CE, Hudkins KL, Floege J, Johnson RJ: Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 1994;5:201-209.
114. Alpers CE, Seifert RA, Hudkins KL, Johnson RJ, Bowen- Pope DF: PDGFreceptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys. Kidney Int 1993;43:286-294.
115. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of muscle- specific actin in glomerulonephritis. Kidney Int 1992; 41:1134-1142.
116. Badid C, Mounier N, Costa AM, Desmou liere A: Role of myofibroblasts during normal tissue repair and excessive scarring: interest of their assessment in nephropathies. Histol Histopathol 2000;15: 269-280.
117. Badid C, Vincent M, Fouque D, Laville M, Desmouliere A: Myofibroblast: a prognostic marker and target cell in progressive renal disease. Ren Fail 2001;23:543-549.
118. Essawy M, Soylemezoglu O, Muchaneta- Kubara EC, Shortland J, Brown CB, el Nahas AM: Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Trans plant 1997;12:43-50.
119. Diamond JR, van GH, Ding G, Engelmyer E: Myofibroblasts in experimental hydronephrosis. Am J Pathol 1995;146:121-129.
120. Floege J, Hackmann B, Kliem V, Kriz , Alpers CE, Johnson RJ, Kuhn KW, Koch KM, Brunkhorst R: Age- related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. Kidney Int 1997;51:230-243.
121. Taneda S, Hudkins KL, Topouzis S, Gilbertson DG, Ophascharoensuk V, Truong L, Johnson RJ, Alpers CE: Obstructive uropathy in mice and humans: potential role for PDGF- D in the progression of tubulointerstitial injury. J Am Soc Nephrol 2003;14:2544-2555.
122. Kimura M, Asano M, Abe K, Miyazaki M, Suzuki T, Hishida A: Role of atrophic changes in proximal tubular cells in the peritubular deposition of type IV collagen in a rat renal ablation model. Nephrol Dial Transplant 2005;20:1559-1565.
123. Lin SL, Kisseleva T, Brenner DA, and Duffield JS: Pericytes and perivascular fibroblasts are the primary source of collagen- producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008;173:1617-1627.
124. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS: Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010;176:185-197.
125. Barnes VL, Musa J, Mitchell RJ, Barnes JL: Expression of embryonic fibronectin isoform EIIIA parallels alpha- smooth muscle actin in maturing and diseased kidney. J Histochem Cytochem 1999;47:787-798.
126. Ahmed A, Huang L, Raftery AT, Ahmed AK, Fahmy H, el Nahas AM, Haylor JL: Cyclosporine A sensitizes the kidney to tubulointerstitial fibrosis induced by renal warm ischemia. Transplantation 2004;77:686-692.
127. Huang L, Haylor JL, Hau Z, Jones RA, Vick ers ME, Wagner B, Griffin M, Saint RE, Coutts IGC, el Nahas AM, Johnson TS: Transglugaminase inhibition ameliorates experimental diabetic nephropathy. Kidney Int 2009;76:383-394.
128. Ma FY, Liu J, Kitching AR, Manthey CL, Nikolic- Paterson DJ: Targeting renal macrophage accumulation via c- fms kinase reduces tubular apoptosis but fails to modi fy progressive fibrosis in the obstructed rat kidney. Am J Physiol Renal Physiol 2009;296: F177-F185.
129. Duymelinck C, Dauwe SE, De Greef KE, Ysebaert DK, Verpooten GA, De Broe ME: TIMP- 1 gene expression and PAI- 1 antigen after unilateral ureteral obstruction in the adult male rat. Kidney Int 2000;58:1186-1201.
130. Suzuki T, Kimura M, Asano M, Fujigaki Y, Hishida A: Role of atrophic tubules in development of interstitial fibrosis in microembolism- induced renal failure in rat. Am J Pathol 2001;158:75-85.
131. Le Hir M, Hegyi I, Cueni- Loffing D, Loffing J, Kaissling B: Characterization of renal interstitial fibroblast- specific protein 1/S100A4- positive cells in healthy and inflamed rodent kidneys. Histochem Cell Biol 2005;123:335-346.
132. Picard N, Baum O, Vogetseder A, Kaissling B, Le Hir M: Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat. Histochem Cell Biol 2008;130:141-155.
133. Kaissling B, Le Hir M: The renal cortical interstitium: morphological and functional aspects. Histochem Cell Biol 2008;130:247-262.
134. Hewitson TD, Wu HL, Becker GJ: Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol 1995;15:411-417.
135. Sharma AK, Mauer SM, Kim Y, Michael AF: Interstitial fibrosis in obstructive nephropathy. Kidney Int 1993;44:774-788.
136. Stokes MB, Holler S, Cui Y, Hudkins KL, Eitner F, Fogo A, Alpers CE: Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease. Kidney Int 2000;57:487-498.
137. Hewitson TD, Becker GJ: Interstitial myofibroblasts in IgA glomerulonephritis. Am J Nephrol 1995;15:111-117.
138. Pedagogos E, Hewitson TD, Walker RG, Nicholis KM, Becker GJ: Myofibroblast involvement in chronic transplant rejection. Transplantation 1997;64:1192-1197.
139. Pat B, Yang T, Kong C, Watters D, Johnson DW, Gobe G: Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int 2005;67:931-943.
140. Zhang G, Oldroyd SD, Huang LH, Yang B, Li Y, Ye R, el Nahas AM: Role of apoptosis and Bcl- 2/Bax in the development of tubulointerstitial fibrosis during experimental obstructive nephropathy. Exp Nephrol 2001;9:71-80.
141. Hewitson TD, Mookerjee I, Masterson R, Zhao C, Tregear GW, Becker GJ, Samuel CS: Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis. Endocrinol 2007;148:660-669.
142. Fujigaki Y, Muranaka Y, Sun D, Goto T, Zhou H, Sakakima M, Fukasawa H, Yonemura K, Yamamoto T, Hishida A: Transient myofibroblast differentiation of interstitial fibroblastic cells relevant to tubular dilatation in uranyl acetate- induced acute renal failure in rats. Virchows Arch 2005;446:164-176.
143. Pozdzik AA, Salmon IJ, Debelle FD, Decaestecker C, Van den Branden C, Verbeelen D, Deschodt- Lanckman MM, Vanherweghem JL, Nortier JL: Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int 2008;73:595-607.
144. Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, Couser WG, Alpers CE: Amelioration of diabetic nephropathy in SPARC- null mice. J Am Soc Nephrol 2003;14:968-980.
145. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS: Cellular distribution of transforming growth factor- beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride- induced rat liver fibrosis. J Clin Invest 1990;85:1833-1843.
146. Hardie WD, Le Cras TD, Jiang K, Tichelaar JW, Azhar M, Korfhagen TR: Conditional expression of transforming growth factor- alpha in adult mouse lung causes pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2004;286:L741-L749.
147. Wiggins R, Goyal M, Merritt S, Killen PD: Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti- glomerular basement membrane antibodyinduced crescentic nephritis in the rabbit. A cellular source for interstitial collagen synthesis in inflammatory renal disease. Lab Invest 1993;68:557-565.
148. Lloyd CM, Dorf ME, Proudfoot A, Salant DJ, Gutierrez- Ramos JC: Role of MCP- 1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J Leukocyte Biol 1997;62:676-680.
149. Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TN, Salant DJ, Gutierrez- Ramos JC: RANTES and monocyte chemoattractant protein- 1 (MCP- 1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP- 1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997;185:1371-1380.
150. Xu Y, Appay MD, Heudes D, Lemoine R, Hinglais N, Michel JB, Bariety J: Colocalization of collagen overexpression and inflammatory cell infiltration in the two- kidney oneclip rat model from the early days of hypertension onward. Virchows Arch 1998;432:267-277.
151. Muchaneta- Kubara EC and el Nahas AM: Myofibroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transplant 1997;12:904-915.
152. Liu G, Changsirikulchai S, Hudkins KL, Banas MC, Kowalewska J, Yang X, Wietecha TA, Volpone J, Gilbertson DG, Alpers CE: Identification of platelet- derived growth factor D in human chronic allograft nephropathy. Human Pathol 2008;39:393-402.
153. Wada T, Sakai N, Matsushima K, Kaneko S: Fibrocytes: a new insight into kidney fibrosis. Kidney Int 2007;72:269-273.
154. Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S, Matsushima K, Kaneko S: Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA 2006;103:14098-14103.
155. Sakai N, Wada T, Matsushima K, Bucala R, Iwai M, Horiuchi M, Kaneko S: The renin- angiotensin system contributes to renal fibrosis through regulation of fibrocytes. J Hypertension 2008;26: 780-790.
156. Broekema M, Harmsen MC, van Luyn MJ, Koerts JA, Petersen AH, van Kooten TG, van GH, Navis G, Popa ER: Bone marrow- derived myofibroblasts contribute to
157. Broekema M, Harmsen MC, Koerts JA, van Kooten TG, Uges DR, Petersen AH, van Luyn MJ, Navis G, Popa ER: Ciclosporin does not influence bone marrow- derived cell differentiation to myofibroblasts early after renal ischemia/reperfusion. Am J Nephrol 2009;30:73-83.
158. Li J, Deane JA, Campanale NV, Bertram JF, Ricardo SD: The contribution of bone marrow- derived cells to the development of renal interstitial fibrosis. Stem Cells 2007;25:697-706.
159. Okon K, Szumera A, Kuzniewski M: Are CD34+ cells found in renal interstitial fibrosis? Am J Nephrol 2003;23:409-414.
160. Grimm PC, Nickerson P, Jeffery J, Savani RC, Gough J, McKenna RM, Stern E, Rush DN: Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal- allograft rejection. N Engl J Med 2001;345:93-97.
161. Roufosse C, Bou- Gharios G, Prodromidi E, Alexakis C, Jeffery R, Khan S, Otto WR, Alter J, Poulsom R, Cook HT: Bone marrow- derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis. J Am Soc Nephrol 2006;17:775-782.
162. Hay ED and Zuk A: Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 1995;26:678-690.
163. Strutz F, Neilson EG: New insights into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol 2003;24:459-476.
164. Iwano M, Neilson EG: Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 2004;13: 279-284.
165. Kalluri R, Neilson EG: Epithelialmesenchymal transition and its implications for fibrosis. J Clin Invest 2003;112:1776-1784.
166. Liu Y: Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004;15:1-12.
167. Liu Y: Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006;69:213-217.
168. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995;130: 393-405.
169. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002;110:341-350.
170. Yang J, Shultz RW, Mars WM, WegnerRE, Li Y, Dai C, Nejak K, Liu Y: Disruption of tissue- type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 2002; 110:1525-1538.
171. Zhang G, Kernan KA, Collins SJ, Cai X, Lopez- Guisa JM, Degen JL, Shvil Y, Eddy AA: Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial- to mesenchymal transition: role of plasmin- activated signals. J Am Soc Nephrol 2007;18:846-859.
172. Bascands JL, Schanstra JP: Obstructive nephropathy: insights from genetically engineered animals. Kidney Int 2005;68:925-937.
173. Kida Y, Asahina K, Teraoka H, Gitelman I, Sato T: Twist relates to tubular epithelial- mesenchymal transition and interstitial fibrogenesis in the obstructed kidney. J Histochem Cytochem 2007;55:661-673.
174. Yang J, Liu Y: Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002;13:96-107.
175. Li Y, Dai C, Wu C, Liu Y: PINCH- 1 promotes tubular epithelial- tomesenchymal transition by interacting with integrin- linked kinase. J Am Soc Nephrol 2007;18:2534-2543.
176. Lange- Sperandio B, Trautmann A, Eickelberg O, Jayachandran A, Oberle S, Schmidutz F, Rodenbeck B, Homme M, Horuk R, Schaefer F: Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am J Pathol 2007;171:861-871.
177. Mao H, Li Z, Zhou Y, Li Z, Zhuang S, An X, Zhang B, Chen W, Nie J, Wang Z, Borkan SC, Wang Y, Yu X: HSP72 attenuates renal tubular cell apoptosis and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 2008;295:F202-F214.
178. Park SH, Choi MJ, Song IK, Choi SY, Nam JO, Kim CD, Lee BH, Park RW, Park KM, Kim YJ, Kim IS, Kwon TH, Kim YL: Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF- beta- induced epithelial- tomesenchymal transition. J Am Soc Nephrol 2007;18:1497-1507.
179. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A: Targeted disruption of TGF- beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003; 112:1486-1494.
180. Tan X, Li Y, Liu Y: Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 2006;17:3382-3393.
181. Yang J, Liu Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001;159:1465-1475.
182. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic- Paterson DJ, Atkins RC, Lan HY: Tubular epithelial- myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998;54:864-876.
183. Kobayashi M, Sugiyama H, Wang DH, Toda N, Maeshima Y, Yamasaki Y, Masuoka N, Yamada M, Kira S, Makino H: Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int 2005;68:1018-1031.
184. Cheng S, Lovett DH: Gelatinase A (MMP- 2) is necessary and sufficient for renal tubular cell epithelialmesenchymal transformation. Am J Pathol 2003;162:1937-1949.
185. Oldfield MD, Bach LA, Forbes JM, Nikolic- Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME: Advanced glycation end products cause epithelialmyofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 2001;108:1853-1863.
186. Li Y, Yang J, Dai C, Wu C, Liu Y: Role for integrin- linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 2003;112:503-516.
187. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas- Bonke V, Thomas MC, Cooper ME, Kantharidis P: Connective tissue growth factor plays an important role in advanced glycation end product- induced tubular epithelial- to- mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006;17:2484-2494.
188. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R: BMP- 7 counteracts TGF- beta1- induced epithelial- tomesenchymal transition and reverses chronic renal injury. Nat Med 2003;9:964-968.
189. Okada H, Ban S, Nagao S, Takahashi H, Suzuki H, Neilson EG: Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int 2000;58:587-597. (Pubitemid 30620008)
190. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R: Fibroblasts in kidney fibrosis emerge via endothelial- to- mesenchymal transition. J Am Soc Nephrol 2008;19:2282-2287.
191. Li J, Qu X, Bertram JF: Endothelialmyofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin- induced diabetic mice. Am J Pathol 2009;175:1380-1388.
192. Cook HT: The origin of renal fibroblasts and progression of kidney disease. Am J Pathol 2010;176: 22-24.
193. Tarin D: The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005;65: 5996-6001.
194. Garber K: Epithelial- to- mesenchymal transition is important to metastasis, but questions remain. J Natl Cancer Inst 2008;100:232-239.
195. Bonventre JV: Kidney injury molecule- 1 (KIM- 1): a specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl 2008;241:78-83.
196. Kramer AB, van Timmeren MM, Schuurs TA, Vaidya VS, Bonventre JV, van GH, Navis G: Reduction of proteinuria in adriamycin- induced nephropathy is associated with reduction of renal kidney injury molecule (Kim- 1) over time. Am J Physiol Renal Physiol 2009;296:F1136-F1145.
197. Kuehn EW, Park KM, Somlo S, Bonventre JV: Kidney injury molecule- 1 expression in murine polycystic kidney disease. Am J Physiol Renal Physiol 2002;283:F1326-F1336.
198. van Timmeren MM, Bakker SJ, Vaidya VS, Bailly V, Schuurs TA, Damman J, Stegeman CA, Bonventre JV, van Goor H: Tubular kidney injury molecule- 1 in protein- overload nephropathy. Am J Physiol Renal Physiol 2006;291:F456-F464.
199. Deniz H, Ogutmen B, Cakalagaoglu F, Tuglular S, Ozener C, Akoglu E: Inhibition of the renin angiotensin system decreases fibrogenic cytokine expression in tacrolimus nephrotoxicity in rats. Transplant Proc 2006;38:483-486.
200. Zhang PL, Rothblum LI, Han WK, Blasick TM, Potdar S, Bonventre JV: Kidney injury molecule- 1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int 2008;73:608-614.
201. Nair RK, Khaira A, Sharma A, Mahajan S, Dinda AK: Spectrum of renal involvement in paroxysmal nocturnal hemoglobinuria: report of three cases and a brief review of the literature. Intl Urol Nephrol 2008;40:471-475.
202. Nath KA, Vercellotti GM, Grande JP, Miyoshi H, Paya CV, Manivel JC, Haggard JJ, Croatt AJ, Payne WD, Alam J: Heme protein- induced chronic renal inflammation: suppressive effect of induced heme oxygenase- 1. Kidney Int 2001;59:106-117.
203. Leonardi P, Ruol A: Renal hemosiderosis in the hemolytic anemias: diagnosis by means of needle biopsy. Blood 1960;16:1029-1038.
204. Le Hir M, Kaissling B: Antibodies against macrophages that overlap in specificity with fibroblasts. Kidney Int 2005;68:2400-2001.
205. Kriz W, Le Hir M: Pathways to nephron loss starting from glomerular diseases- insights from animal models. Kidney Int 2005;67:404-419.
206. Schnaper HW, Kopp JB: Why kidneys fail: report from an American Society of Nephrology Advances in Research Con ference. J Am Soc Nephrol 2006;17:1777-1781.
207. Kriz W: Histopathological analysis of interstitial fibrosis. Epithelial mesenchymal transition in fibrosis: whither the controversy? Symposium Panel: Morrissey JJ, Liu Y, Lovett DH, Barnes JL, Kriz W. American Society of Nephrology Renal Week San Diego, 2006.
208. Nishitani Y, Iwano M, Yamaguchi Y, Harada K, Nakatani K, Akai Y, Nishino T, Shiiki H, Kanauchi M, Saito Y, Neilson EG: Fibroblastspecific protein 1 is a specific prognostic marker for renal survival in patients with IgAN. Kidney Int 2005;68:1078-1085.
209. Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, Eckardt KU, Iwano M, Haase VH: Hypoxia promotes fibrogenesis in vivo via HIF- 1 stimulation of epithelial- tomesenchymal transition. J Clin Invest 2007;117:3810-3820.
210. Higgins DF, Kimura K, Iwano M, Haase VH: Hypoxia- inducible factor signaling in the development of tissue fibrosis. Cell Cycle 2008;7:1128-1132.
211. Nishida M, Hamaoka K: Macrophage phenotype and renal fibrosis in obstructive nephropathy. Nephron Exp Nephrol 2008;110:e31-e36.
212. Ito K, Chen J, El CM, Stern JM, Seshan SV, Khodadadian JJ, Richardson I, Hyman MJ, Vaughan ED Jr, Poppas DP, Felsen D: Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. Am J Physiol Renal Physiol 2004;287:F1283-F1293.
213. Mazzucchelli L: Protein S100A4: too long overlooked y pathologists? Am J Pathol 2002;160:7-13.
214. Garrett SC, Varney KM, Weber DJ, Bresnick AR: S100A4, a mediator of metastasis. J Biol Chem 2006;281:677-680.
215. Duarte WR, Shibata T, Takenaga K, Takahashi E, Kubota K, Ohya K, Ishikawa I, Yamauchi M, Kasugai S: S100A4: a novel negative regulator of mineralization and osteoblast differentiation. J Bone Miner Res 2003;18:493-501.
216. Gibbs FE, Barraclough R, Platt- Higgins A, Rudland PS, Wilkinson MC, Parry EW: Immunocytochemical distribution of the calcium- binding protein p9Ka in normal rat tissues: variation in the cellular location in different tissues. J Histochem Cytochem1995;43:169-180.
217. Rivard CJ, Brown LM, Almeida NE, Maun sbach AB, Pihakaski- Maunsbach K, Andres- Hernando A, Capasso JM, Berl T: Expression of the calcium- binding protein S100A4 is markedly up- regulated by osmotic stress and is involved in the renal osmoadaptive response. J Biol Chem 2007;282:6644-6652.
218. Carvajal G, Droguett A, Burgos ME, Aros C, Ardiles L, Flores C, Carpio D, Ruiz- Ortega M, Egido J, Mezzano S: Gremlin: a novel mediator of epithelial mesenchymal transition and fibrosis in chronic allograft nephropathy. Transplant Proc 2008;40:734-739.
219. Djamali A, Vidyasagar A, Adulla M, Hullett D, Reese S: Nox- 2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant 2009;9:74-82.
220. Tyler JR, Robertson H, Booth TA, Burt AD, Kirby JA: Chronic allograft nephropathy: intraepithelial signals generated by transforming growth factor- beta and bone morphogenetic protein- 7. Am J Transplant 2006; 6:1367-1376.
221. Jinde K, Nikolic- Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC, Lan HY: Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 2001;38:761-769.
222. Vongwiwatana A, Tasanarong A, Rayner DC, Melk A, Halloran PF: Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant 2005;5:1367-1374.
223. Rastaldi MP, Ferrario F, Giardino L, DellAntonio G, Grillo C, GrilloP, Strutz F, Muller GA, Colasanti G, DAmico G: Epithelial- mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002;62:137-146.
224. Inoue T, Okada H, Takenaka T, Watanabe Y, Suzuki H: A case report suggesting the occurrence of epithelial- mesenchymal transition in obstructive nephropathy. Clin Exp Nephrol 2009;13:385-388.
225. Zeisberg M, Maeshima Y, Mosterman B, Kalluri R: Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am J Pathol 2002;160:2001-2008.
226. Vitalone MJ, OConnell PJ, Jimenez- Vera E, Yuksel A, Wavamunno M, Fung CL, Chapman JR, Nankivell BJ: Epithelial- to- mesenchymal transition in early transplant tubulointerstitial damage. J Am Soc Nephrol 2008;19:1571-1583.
227. Kuusniemi AM, Lapatto R, Holmberg C, Karikoski R, Rapola J, Jalanko H: Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic change. Kidney Int 2005;68:121-132.
228. Zeisberg M, Duffield JS: Resolved: EMT produces fibroblasts in the kidney. Debate. J Am Soc Nephrol 2010;21:1247-1253.
229. Li L, Zepeda-Orozoco D, Black R, Lin F: Autophagy is a component of epithelial cell fate in obstructive uropathy. Am J Pathol 2010;176:1767-1778.
230. Koesters R, Kaissling B, Le Hir M, Picard N, Theilig F, Gebhardt R, Glick AB, Hahnel B, Hosser H, Grone H-J, Kriz W: Tubular overexpression of transforming growth factor-b1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010;177:632-643.